Clinical Utility of Circulating Tumor Cells
Автор: OncLive
Загружено: 2014-12-05
Просмотров: 463
Mark C. Connelly, PhD, from Janssen Research & Development, suggests that circulating tumor cells (CTCs) are an effective independent predictor of progression-free survival and overall survival. CTCs can be used to monitor patients during treatment.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: